Legend Biotech (FRA:9LB) Total Liabilities : €562.2 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Legend Biotech Total Liabilities?

Legend Biotech's Total Liabilities for the quarter that ended in Mar. 2024 was €562.2 Mil.

Legend Biotech's quarterly Total Liabilities increased from Sep. 2023 (€468.22 Mil) to Dec. 2023 (€547.67 Mil) and increased from Dec. 2023 (€547.67 Mil) to Mar. 2024 (€562.16 Mil).

Legend Biotech's annual Total Liabilities increased from Dec. 2021 (€312.87 Mil) to Dec. 2022 (€553.80 Mil) but then declined from Dec. 2022 (€553.80 Mil) to Dec. 2023 (€547.67 Mil).

Legend Biotech Total Liabilities Historical Data

The historical data trend for Legend Biotech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Legend Biotech Total Liabilities Chart

Legend Biotech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

369.53

102.19

312.87

553.80

547.67

Legend Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															519.49	483.31	468.22	547.67	562.16

Legend Biotech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Legend Biotech's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	198.455	+	(298.481	+	0.050999999999995
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	50.68	+	0)
	=	547.7

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1695.174	-	1147.507
	=	547.7

Legend Biotech's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	229.701	+	(305.044	+	0.027999999999984
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	27.391	+	0)
	=	562.2

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	1633.098	-	1070.934
	=	562.2

Legend Biotech Total Liabilities Related Terms

Thank you for viewing the detailed overview of Legend Biotech's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Legend Biotech (FRA:9LB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Legend Biotech Corp (FRA:9LB) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

LEGN:USA

Address

2101 Cottontail Lane, Somerset, NJ, USA, 08873

Website

https://www.legendbiotech.com

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America.

Legend Biotech (FRA:9LB) Headlines

No Headlines